[ Price : $8.95]
Advocacy group Public Citizen files a petition urging FDA to ban prescription drug direct-to-consumer advertising.[ Price : $8.95]
FDA accepts for review Revolution Medicines' NDA for daraxonrasib, an investigational oral RAS-targeted therapy for patients with ...[ Price : $8.95]
Attorney Megan Robertsons analysis of 2026 FDA Warning Letters shows that CDER has been the most active Center, going after telehe...[ Price : $8.95]
FDA releases the form FDA-483 issued following a 2026 inspection at the CSL Behring biological drug manufacturing facility in Marb...[ Price : $8.95]
FDA publishes a strategy document on facilitating chemistry, manufacturing, and controls readiness for products in accelerated dev...[ Price : $8.95]
Former FDA commissioner Rob Califf tells a cardiology technology convention that the U.S. needs to make significant changes to imp...[ Price : $8.95]
The Senate HELP Committee advances legislation sponsored by Sen. Rand Paul that he says will speed approval of biosimilar drugs by...[ Price : $8.95]
A just-posted Form FDA 483 cites SGS France Life Sciences following an 8/2025 inspection, identifying multiple deficiencies involv...